452
Participants
Start Date
March 31, 2014
Primary Completion Date
July 31, 2014
Study Completion Date
July 31, 2014
artemether-lumefantrine (AL)
Dispersible formulation of artemether-lumefantrine (Coartem-D™; 20mg artemether/120mg lumefantrine per tablet, Novartis, Switzerland) administered twice a day for 3 days according to manufacturer recommended dosing for weight
artesunate-amodiaquine (ASAQ)
Co-formulated artesunate-amodiaquine (25mg artesunate/67.5mg amodiaquine and 50mg artesunate/135mg amodiaquine tablets) administered once a day for 3 days, according to manufacturer recommended dosing for weight
Malaria Alert Center, University of Malawi College of Medicine, Blantyre, Malawi, Blantyre
Kamuzu University of Health Sciences
OTHER
Centers for Disease Control and Prevention
FED